Analyst Reaffirms Buy Rating on Inozyme Pharma with 23 Price Target
On March 12, 2024, analyst Joseph Stringer from Needham reiterated his bullish stance on Inozyme Pharma (NASDAQ: INZY), affirming a...
On March 12, 2024, analyst Joseph Stringer from Needham reiterated his bullish stance on Inozyme Pharma (NASDAQ: INZY), affirming a...
Imagine if you had invested $1000 in Arista Networks (NYSE: ANET) five years ago. Today, your investment would be worth...
Analyst Laura Champine of Loop Capital has decided to maintain a Hold rating on Lowe's Companies (NYSE: LOW) while increasing...
Geron shares took a hit today as news broke that FDA staff reviewers have raised red flags about the potential...
Bright Green's stock is on the rise after unveiling plans for a major expansion endeavor. This initiative involves a lucrative...
Heartbeam Inc (BEAT) shares are up 3.5% to $2.35 on March 12, 2024, slightly lower than its peak of $2.70...
If you had invested $100 in Carlisle Companies (NYSE:CSL) a decade ago, it would now be valued at $460.51 as...
Over the past quarter, analysts have shared a range of opinions on Lantronix (NASDAQ: LTRX), with a mix of optimism...
Earnings Preview for Portman Ridge Finance Portman Ridge Finance (NASDAQ: PTMN) is set to unveil its quarterly earnings report on...
Apple, a prominent player in the Technology Hardware, Storage & Peripherals sector, distinguishes itself with its wide range of hardware...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.